Published in:
01-08-2010 | Letter
RAD51C germline mutations in breast and ovarian cancer patients
Authors:
Mohammad R Akbari, Patricia Tonin, William D Foulkes, Parviz Ghadirian, Marc Tischkowitz, Steven A Narod
Published in:
Breast Cancer Research
|
Issue 4/2010
Login to get access
Excerpt
The two breast cancer genes
BRCA1 and
BRCA2 account for approximately one-half of cases of hereditary breast cancer, and other genes, such as
BRIP1,
PALB2, and
P53, account for a small additional fraction [
1]. Recently, it has been proposed that
RAD51C is also a breast cancer susceptibility gene [
2]. A bi-allelic mutation of
RAD51C was originally found in a family from Pakistan with features of Fanconi anemia [
3]. Because several genes in the Fanconi anemia gene family are also breast cancer susceptibility genes (including
BRCA2 (
FANCD1) [
4],
BRIP1 (
FANCJ) [
5] and
PALB2 (
FANCN) [
6]), Meindl and colleagues hypothesised that
RAD51C might be a breast cancer gene [
2]. A germline mutation was seen in 6 of 480 (1.3%) breast/ovarian cancer families from Germany, which had previously been found to be negative for mutations in
BRCA1 and
BRCA2. In each of the six families, the putative mutation co-segregated with the relevant cancers [
2]. Each family with a mutation contained at least one case each of breast and ovarian cancer. …